NYSEAMERICAN:XTNT

Xtant Medical Stock Forecast, Price & News

$1.96
+0.02 (+1.03 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.92
Now: $1.96
$2.05
50-Day Range
$1.15
MA: $1.24
$1.48
52-Week Range
$0.63
Now: $1.96
$6.58
Volume113,734 shs
Average Volume3.59 million shs
Market Capitalization$169.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Xtant Medical logo

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:XTNT
CUSIPN/A
Phone+1-406-3880480
Employees110
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$169.95 million
Next Earnings Date5/6/2021 (Estimated)
OptionableNot Optionable

Headlines

Xtant Medical Comments on Trading Activity of its Stock
February 26, 2021 |  finance.yahoo.com
Xtant Medical Holdings, Inc. to Host Earnings Call
February 24, 2021 |  finance.yahoo.com
Xtant Medical Announces $20 Million Private Placement
February 22, 2021 |  finance.yahoo.com
Xtant Medical Holdings, Inc.
December 12, 2020 |  fool.com
Xtant Medical Announces Expiration of Rights Offering
December 7, 2020 |  finance.yahoo.com
Xtant Medical EPS beats by $0.01, misses on revenue
October 29, 2020 |  seekingalpha.com
Xtant Medical sets record date for $15M rights offering
October 22, 2020 |  seekingalpha.com
See More Headlines

MarketRank

Overall MarketRank

0.56 out of 5 stars

Medical Sector

1468th out of 2,024 stocks

Medical Devices Industry

12th out of 30 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$1.96
+0.02 (+1.03 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

What stocks does MarketBeat like better than Xtant Medical?

Wall Street analysts have given Xtant Medical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Xtant Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Xtant Medical?

Xtant Medical saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 60,100 shares, a drop of 76.8% from the March 15th total of 258,900 shares. Based on an average trading volume of 4,140,000 shares, the days-to-cover ratio is presently 0.0 days.
View Xtant Medical's Short Interest
.

When is Xtant Medical's next earnings date?

Xtant Medical is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Xtant Medical
.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) issued its earnings results on Wednesday, February, 24th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.11. The medical device company had revenue of $14.02 million for the quarter.
View Xtant Medical's earnings history
.

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Shares of Xtant Medical reverse split on the morning of Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the following people:
  • Mr. Sean E. Browne, Pres, CEO & Director (Age 55, Pay $1.19M)
  • Mr. Greg Jensen, VP of Fin. & CFO (Age 60, Pay $645.08k)
  • Mr. Kevin D. Brandt, Sr. VP & Chief Commercial Officer (Age 55, Pay $605.33k)
  • Ms. Catherine Lundy, VP of HR
  • Mr. Kevin M. O'Dare, VP of Sales - Eastern US

Who are some of Xtant Medical's key competitors?

What other stocks do shareholders of Xtant Medical own?

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $1.96.

How much money does Xtant Medical make?

Xtant Medical has a market capitalization of $169.95 million.

How many employees does Xtant Medical have?

Xtant Medical employs 110 workers across the globe.

What is Xtant Medical's official website?

The official website for Xtant Medical is xtantmedical.com.

Where are Xtant Medical's headquarters?

Xtant Medical is headquartered at 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.


This page was last updated on 4/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.